Pancreatic endocrine effects of dopamine receptors in human islet cells

Pancreas

Volumn 44, Issue 6, 2015, Pages 925-929

  Zhang, Ying ^a   Zheng, Ruipan ^b   Meng, Xiangzhi ^a   Wang, Lulu ^a   Liu, Li ^a   Gao, Yan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

dopamine; dopamine receptors; insulin; islets of Langerhans

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; PANCREAS POLYPEPTIDE; PARAFORMALDEHYDE; DOPAMINE RECEPTOR; DRD1 PROTEIN, HUMAN; DRD2 PROTEIN, HUMAN; DRD3 PROTEIN, HUMAN; DRD4 PROTEIN, HUMAN; DRD5 PROTEIN, HUMAN; PARAFFIN;

ARTICLE; CONFOCAL MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; CHEMISTRY; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; PANCREAS ISLET; PANCREATIC POLYPEPTIDE SECRETING CELL; SOMATOSTATIN CELL;

FLUORESCENT ANTIBODY TECHNIQUE; GLUCAGON-SECRETING CELLS; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MICROSCOPY, CONFOCAL; PANCREATIC POLYPEPTIDE-SECRETING CELLS; PARAFFIN EMBEDDING; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; RECEPTORS, DOPAMINE D5; SOMATOSTATIN-SECRETING CELLS;

EID: 84937904927     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000357     Document Type: Article

References (16)

1. Beaulieu JM, Gainetdinov RR,. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011; 63: 182-217
2. Khan ZU, Mrzljak L, Gutierrez A, Prominence of the dopamine D2 short isoform in dopaminergic pathways. Proc Natl Acad Sci U S A. 1998; 95: 7731-7736
3. Wood-Kaczmar A, Gandhi S, Wood NW,. Understanding the molecular causes of Parkinson's disease. Trends Mol Med. 2006; 12: 521-528
4. Rubi B, Maechler P,. Minireview: new roles for peripheral dopamine on metabolic control and tumor growth: let's seek the balance. Endocrinology. 2010; 151: 5570-5581
5. Vallone D, Picetti R, Borrelli E,. Structure and function of dopamine receptors. Neurosci Biobehav Rev. 2000; 24: 125-132
6. Ruipan Z, Xiangzhi M, Li L, Differential expression and localization of neuropeptide Y peptide in pancreatic islet of diabetic and high fat fed rats. Peptides. 2014; 54: 33-38
7. Matschinsky FM, Ellerman JE,. Metabolism of glucose in the islets of Langerhans. J Biol Chem. 1968; 243: 2730-2736
8. Melkersson K, Khan A, Hilding A, Different effects of antipsychotic drugs on insulin release in vitro. Eur Neuropsychopharmacol. 2001; 11: 327-332
9. Rubi B, Ljubicic S, Pournourmohammadi S, Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. J Biol Chem. 2005; 280: 36824-36832
10. Taborsky GJ Jr,. The physiology of glucagon. J Diabetes Sci Technol. 2010; 4: 1338-1344
11. Mezey E, Eisenhofer G, Harta G, A novel nonneuronalcatecholaminergic system: exocrine pancreas synthesizes and releases dopamine. Proc Natl Acad Sci U S A. 1996; 93: 10377-10382
12. Ustione A, Piston DW,. Dopamine synthesis and D3 receptor activation in pancreatic beta-cells regulates insulin secretion and intracellular [Ca(2+)] oscillations. Mol Endocrinol. 2012; 26: 1928-1940
13. Chen Y, Hong F, Chen H, Distinctive expression and cellular distribution of dopamine receptors in the pancreatic islets of rats. Cell Tissue Res. 2014
14. Shankar E, Santhosh KT, Paulose CS,. Dopaminergic regulation of glucose-induced insulin secretion through dopamine D2 receptors in the pancreatic islets in vitro. IUBMB Life. 2006; 58: 157-163
15. Schuit FC, Huypens P, Heimberg H, Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes. 2001; 50: 1-11
16. Garcia-Tornadu I, Ornstein AM, Chamson-Reig A, Disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance. Endocrinology. 2010; 151: 1441-1450